Solveig Tangedal

PhD Candidate

Academic article

Show author(s) (2022). The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis. Microbiome. 11 pages.
Show author(s) (2022). The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease . PLOS ONE.
Show author(s) (2022). A longitudinal study of the pulmonary mycobiome in subjects with and without chronic obstructive pulmonary disease. PLOS ONE. 15 pages.

Show author(s) (2020). The airway microbiota and exacerbations of COPD. European Respiratory Journal Open Research (ERJ Open Research). 1-10.

Show author(s) (2019). Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients. PLOS ONE. 1-18.

Show author(s) (2017). Protected sampling is preferable in bronchoscopic studies of the airway microbiome. European Respiratory Journal Open Research (ERJ Open Research).
Show author(s) (2017). Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients. Respiratory Research. 1-9.

Show author(s) (2014). Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients. Respiratory Research.

Abstract

Show author(s) (2019). Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels. European Respiratory Journal.

Show author(s) (2014). Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients. European Respiratory Journal.